E

Psyched Wellness Ltd. PSYC

CNSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Psyched Wellness Ltd. is a Canada-based life sciences company operating in the nutraceutical, functional food, and wellness industries, with a strategic focus on products derived from the Amanita muscaria mushroom. The company’s primary business involves the development, commercialization, and sale of legal, non-psychedelic mushroom-derived consumer products intended to support relaxation, sleep, and overall wellness. Psyched Wellness does not operate in the controlled psychedelic drug development space; instead, it positions itself within the regulated consumer health and wellness market.

The company’s principal revenue driver is its Amanita muscaria-derived branded product, Calm, which is marketed as a legal wellness supplement in jurisdictions where permitted. Psyched Wellness targets health-conscious consumers, wellness retailers, and direct-to-consumer customers, primarily in North America. Its strategic positioning is based on being one of the first publicly traded companies to commercialize Amanita muscaria products at scale while emphasizing compliance, safety testing, and standardized extraction processes. The company was incorporated in 2020 and evolved from early-stage research and intellectual property development into commercial sales following regulatory reviews and supply chain establishment.

Data compiled by narrative technology. May contain errors.

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Friday, July 24, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
647 400 8494
Address
36 Toronto Street
Suite 701
Toronto, ON M5C 2C5
Country
Year Founded
--

Headlines

There are no news to display.